FDA Adverse Event Malfunction Summary report: N

HEARTWARE VENTRICULAR ASSIST SYSTEM - BATTERY

MDR report key: 7779119 · Received August 13, 2018

Report

Report Number
3007042319-2018-03702
Event Type
Malfunction
Date Received
August 13, 2018
Date of Event
July 27, 2018
Report Date
September 17, 2018
Manufacturer
HEARTWARE, INC.
Product Code
DSQ
UDI-DI
00888707000369
PMA / PMN Number
P100047
Removal / Correction Number
Z-1903-2018
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
PA, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 0

PRODUCT EVENT SUMMARY: THE BATTERIES (BAT585608, BAT584626, BAT584631, BAT584625, BAT585610, BAT584610) WERE NOT RETURNED FOR EVALUATION. LOG FILE ANALYSIS WAS NOT CONDUCTED SINCE LOG FILES WERE NOT AVAILABLE. AS A RESULT, THE REPORTED EVENT COULD NOT BE CONFIRMED. A POWER SOURCE LUBRICATION PROCEDURE WAS PERFORMED IN ACCORDANCE WITH THE REQUIREMENTS UNDER AN INTERNAL INVESTIGATOIN TO MITIGATE THE REPORTED CONDITIONS AND THE BATTERIES REMAINED IN USE. APPLICABLE RISK DOCUMENTATION AND EXPERIENCE WITH EVENTS OF SIMILAR CIRCUMSTANCES WERE CONSIDERED; A POSSIBLE ROOT CAUSE OF THE REPORTED PREMATURE POWER SWITCHING EVENTS CAN BE ATTRIBUTED TO COMMUNICATION ERRORS AND/OR MOMENTARY DISCONNECTIONS BETWEEN THE CONTROLLER AND BATTERY. HOWEVER, THE REPORTED BEEPS ARE MOST LIKELY ATTRIBUTED TO MOMENTARY DISCONNECTIONS BETWEEN THE CONTROLLER AND BATTERY. ADDITIONAL PRODUCTS: BATTERY BAT584626 H6 FDA METHOD CODE(S): 4114, 4112. FDA RESULTS CODE(S): 3221 H6 FDA CONCLUSION CODE(S): 4315 BATTERY BAT584631 H6 FDA METHOD CODE(S): 4114, 4112 H6 FDA RESULTS CODE(S): 3221 H6 FDA CONCLUSION CODE(S): 4315 BATTERY BAT584625 H6 FDA METHOD CODE(S): 4114, 4112 H6 FDA RESULTS CODE(S): 3221 H6 FDA CONCLUSION CODE(S): 4315 BATTERY BAT585610 H6 FDA METHOD CODE(S): 4114, 4112 H6 FDA RESULTS CODE(S): 3221 H6 FDA CONCLUSION CODE(S): 4315 BATTERY BAT584610 H6 FDA METHOD CODE(S): 4114, 4112 H6 FDA RESULTS CODE(S): 3221 H6 FDA CONCLUSION CODE(S): 4315 MEDTRONIC, INC. (MEDTRONIC) IS SUBMITTING THIS REPORT TO COMPLY WITH 21 C.F.R. PART 803, THE MEDICAL DEVICE REPORTING REGULATION. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION IN THE TIME ALLOTTED AND HAS PROVIDED AS MUCH INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC OR ITS EMPLOYEES CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY "DEFECTS" OR HAS "MALFUNCTIONED". THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA, TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REPORTING PURSUANT TO PART 803. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE IT BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. ANY REQUIRED FIELDS THAT ARE UNPOPULATED ARE BLANK BECAUSE THE INFORMATION IS CURRENTLY UNKNOWN OR UNAVAILABLE. A GOOD FAITH EFFORT WILL BE MADE TO OBTAIN THE APPLICABLE INFORMATION RELEVANT TO THE REPORT. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Additional Manufacturer Narrative · 1

THIS DEVICE IS USED FOR TREATMENT NOT DIAGNOSIS. THE VENTRICULAR ASSIST SYSTEM IS INDICATED FOR USE AS A BRIDGE TO CARDIAC TRANSPLANTATION AND DESTINATION THERAPY IN PATIENTS WHO ARE AT RISK OF DEATH FROM REFRACTORY END-STAGE LEFT VENTRICULAR HEART FAILURE. THE SYSTEM IS DESIGNED FOR IN-HOSPITAL AND OUT-OF-HOSPITAL SETTINGS. OTHER DEVICES INVOLVED IN THIS EVENT: HEARTWARE VENTRICULAR ASSIST SYSTEM ¿ BATTERY / (B)(4)/ MODEL #: 1650DE / EXPIRATION DATE: 2018-08-31 UDI #: (B)(4) MFG DATE: 2017-08-31 (B)(4). HEARTWARE VENTRICULAR ASSIST SYSTEM ¿ BATTERY/ (B)(4)/ MODEL #: 1650DE / EXPIRATION DATE: 2018-08-31 UDI #: (B)(4) MFG DATE: 2017-08-31 (B)(4). HEARTWARE VENTRICULAR ASSIST SYSTEM ¿ BATTERY / (B)(4)/ MODEL #: 1650DE / EXPIRATION DATE: 2018-08-31 UDI #: (B)(4) MFG DATE: 2017-08-31 (B)(4). HEARTWARE VENTRICULAR ASSIST SYSTEM ¿ BATTERY / (B)(4) / MODEL #: 1650DE / EXPIRATION DATE: 2018-08-31 UDI #: (B)(4) MFG DATE: 2017-08-31 (B)(4). HEARTWARE VENTRICULAR ASSIST SYSTEM ¿ BATTERY / (B)(4)/ MODEL #: 1650DE / EXPIRATION DATE: 2018-08-31 UDI #: (B)(4) MFG DATE: 2017-08-31 (B)(4). IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Description of Event or Problem · 1

IT WAS REPORTED THAT SIX VENTRICULAR ASSIST DEVICE (VAD) BATTERIES EXHIBITED OCCASIONAL POWER SWITCHING DESPITE HAVING GREATER THAN TWENTY-FIVE PERCENT CHARGE CAPACITY AND THE PATIENT "OCCASIONALLY HEARS A SINGLE BEEP." LUBRICATION SERVICING WAS PERFORMED ON THE BATTERIES AND THEY REMAIN IN USE. NO PATIENT COMPLICATIONS HAVE BEEN REPORTED AS A RESULT OF THIS EVENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
619894 HEARTWARE VENTRICULAR ASSIST SYSTEM - BATTERY VENTRICULAR (ASSISST) BYPASS DSQ HEARTWARE, INC. 1650DE 00888707000369

Patients

Seq Age Sex Outcome Treatment
1 58 YR 1103 VAD